| Balance Sheet of Alembic Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
39.31 |
39.31 |
39.31 |
39.31 |
39.31 |
|
| Total Share Capital |
39.31 |
39.31 |
39.31 |
39.31 |
39.31 |
|
| Reserves and Surplus |
5,151.64 |
4,778.89 |
4,331.16 |
5,198.23 |
5,088.30 |
|
| Total Reserves and Surplus |
5,151.64 |
4,778.89 |
4,331.16 |
5,198.23 |
5,088.30 |
|
| Total Shareholders Funds |
5,190.95 |
4,818.20 |
4,370.47 |
5,237.54 |
5,127.61 |
|
| Minority Interest |
-1.42 |
0.00 |
0.00 |
0.00 |
-60.64 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
0.00 |
0.00 |
0.00 |
0.00 |
199.89 |
|
| Deferred Tax Liabilities [Net] |
0.00 |
0.00 |
0.00 |
0.00 |
4.21 |
|
| Other Long Term Liabilities |
46.77 |
62.88 |
69.23 |
72.14 |
71.54 |
|
| Long Term Provisions |
124.31 |
109.51 |
106.20 |
95.82 |
85.52 |
|
| Total Non-Current Liabilities |
171.08 |
172.39 |
175.43 |
167.96 |
361.16 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
1,195.57 |
430.45 |
635.87 |
629.99 |
0.02 |
|
| Trade Payables |
879.89 |
735.64 |
679.81 |
706.39 |
668.77 |
|
| Other Current Liabilities |
251.00 |
223.65 |
251.19 |
316.51 |
560.07 |
|
| Short Term Provisions |
85.87 |
65.25 |
70.06 |
63.64 |
51.99 |
|
| Total Current Liabilities |
2,412.33 |
1,454.99 |
1,636.93 |
1,716.53 |
1,280.85 |
|
| Total Capital And Liabilities |
7,772.94 |
6,445.58 |
6,182.83 |
7,122.03 |
6,708.98 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
2,523.53 |
2,546.71 |
2,398.45 |
1,741.47 |
1,703.74 |
|
| Intangible Assets |
0.00 |
0.00 |
0.00 |
56.38 |
85.55 |
|
| Capital Work-In-Progress |
837.23 |
524.36 |
601.28 |
2,205.79 |
1,944.28 |
|
| Fixed Assets |
3,360.76 |
3,071.07 |
2,999.73 |
4,102.08 |
3,970.96 |
|
| Non-Current Investments |
127.21 |
93.02 |
96.33 |
118.40 |
49.31 |
|
| Deferred Tax Assets [Net] |
166.03 |
169.64 |
123.01 |
5.88 |
0.00 |
|
| Long Term Loans And Advances |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Other Non-Current Assets |
31.15 |
33.29 |
53.74 |
34.88 |
110.81 |
|
| Total Non-Current Assets |
3,685.15 |
3,367.02 |
3,272.81 |
4,261.24 |
4,131.08 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
0.00 |
0.00 |
0.00 |
0.00 |
186.97 |
|
| Inventories |
2,288.14 |
1,643.54 |
1,475.27 |
1,609.70 |
1,486.15 |
|
| Trade Receivables |
1,399.79 |
1,024.84 |
1,046.40 |
807.13 |
348.58 |
|
| Cash And Cash Equivalents |
90.10 |
126.57 |
82.27 |
69.43 |
105.84 |
|
| Short Term Loans And Advances |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| OtherCurrentAssets |
309.76 |
283.61 |
306.08 |
374.53 |
450.36 |
|
| Total Current Assets |
4,087.79 |
3,078.56 |
2,910.02 |
2,860.79 |
2,577.90 |
|
| Total Assets |
7,772.94 |
6,445.58 |
6,182.83 |
7,122.03 |
6,708.98 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
189.48 |
183.13 |
317.96 |
228.15 |
349.23 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Non-Current Investments Unquoted Book Value |
25.72 |
68.61 |
71.20 |
63.69 |
0.45 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Current Investments Unquoted Book Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
